|
 |
Cancer Liaison Program
The staff of the Cancer Liaison Program, located in FDA's Office
of Special Health Issues, work with FDA's oncology medical staff
to bring the patient advocate's perspective into the review
of new drugs to treat cancer. The staff also meets with organized
patient advocacy groups to listen to their concerns about drug
development and to assist them in understanding the FDA drug
regulatory process. Calls from cancer patients and their loved
ones are routinely answered by the staff to help callers with
questions about cancer clinical trials and/or cancer drug development.
This program incorporates the perspective of cancer patient
advocates into the drug development process allowing them an
opportunity to participate in the FDA drug review regulatory
process.
This program was charged with developing a process for recruiting,
assessing, and selecting patient representatives to serve as
members of advisory committees.
Overivew of the 1996 "FDA Initiative on Reinventing the
Regulation of Cancer Drugs" role in patient representation
on cancer-related FDA advisory committees.
|
|
|
|
information related to cancer and approved cancer drug therapies
Provides patients, family members and members of the public
current information about clinical research studies, and basic
information about clinical trials
National Institute of Health information about cancer research,
cancer statistics, and other cancer-related information
|
|
|
Contact Us
|
|
|
